# Gliflozins on HF in Regurgitant Rheumatic Heart

> **NCT06097585** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 150 (estimated)

## Conditions studied

- Rheumatic Heart Disease
- Heart Failure

## Interventions

- **DRUG:** SGLT2 inhibitor

## Key facts

- **NCT ID:** NCT06097585
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097585, "Gliflozins on HF in Regurgitant Rheumatic Heart". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06097585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*